Home > Balance Sheet > INDOCO REMEDIES

INDOCO REMEDIES
Contingent Liabilities

    Back to Balance Sheet
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹163 Cr₹164 Cr₹89 Cr₹60 Cr₹56 Cr

What is the latest Contingent Liabilities ratio of INDOCO REMEDIES ?

The latest Contingent Liabilities ratio of INDOCO REMEDIES is ₹163 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹163 Cr
Mar2024₹164 Cr
Mar2023₹89 Cr
Mar2022₹60 Cr
Mar2021₹56 Cr

How is Contingent Liabilities of INDOCO REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2025 ₹163 Cr
-0.60
Mar2024 ₹164 Cr
83.75
Mar2023 ₹89 Cr
48.09
Mar2022 ₹60 Cr
7.79
Mar2021 ₹56 Cr -

Compare Contingent Liabilities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,026.4 Cr -11.4% -9.8% -32.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-11.4%

-9.8%

-32.6%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses